Medicover AB (MCVEF)
27.25
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.114B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 38.59% |
| Valuation | |
| PE Ratio | 47.04 |
| PE Ratio (Forward) | |
| PS Ratio | 1.530 |
| Price to Book Value | 6.575 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.2379 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 2.702 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 70.77% |
Profile
| Medicover AB engages in the provision of invitro diagnostics and healthcare services. It operates through the Healthcare Services and Diagnostic Services segments. The Healthcare Services segment includes the provision of employer funded healthcare services for employees and sometimes their families. The Diagnostic Services segment offers a broad range of routine and advanced laboratory testing across all clinical pathology areas. The company was founded in 1995 and is headquartered in Stockholm, Sweden. |
| URL | http://www.medicover.com |
| Investor Relations URL | N/A |
| HQ State/Province | Stockholm |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | Apr. 29, 2026 |
| Last Earnings Release | Feb. 10, 2026 |
| Next Ex-Dividend Date | May. 04, 2026 |
| Last Ex-Dividend Date | May. 02, 2025 |
Profile
| Medicover AB engages in the provision of invitro diagnostics and healthcare services. It operates through the Healthcare Services and Diagnostic Services segments. The Healthcare Services segment includes the provision of employer funded healthcare services for employees and sometimes their families. The Diagnostic Services segment offers a broad range of routine and advanced laboratory testing across all clinical pathology areas. The company was founded in 1995 and is headquartered in Stockholm, Sweden. |
| URL | http://www.medicover.com |
| Investor Relations URL | N/A |
| HQ State/Province | Stockholm |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | Apr. 29, 2026 |
| Last Earnings Release | Feb. 10, 2026 |
| Next Ex-Dividend Date | May. 04, 2026 |
| Last Ex-Dividend Date | May. 02, 2025 |
